Contribution of Involved-field Radiotherapy to Survival in Patients With Relapsed or Refractory Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplantation


Eroglu C., KAYNAR L., ORHAN O., Keklik M., Sahin C., YILDIZ O., ...More

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, vol.38, no.1, pp.68-73, 2015 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 38 Issue: 1
  • Publication Date: 2015
  • Doi Number: 10.1097/coc.0b013e3182880b9f
  • Journal Name: AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.68-73
  • Keywords: Hodgkin lymphoma, chemoradiotherapy, autologous stem cell transplantation, HIGH-DOSE CHEMOTHERAPY, BONE-MARROW-TRANSPLANTATION, RADIATION-THERAPY, EUROPEAN GROUP, WORKING PARTY, DISEASE, BLOOD, CHEMORADIOTHERAPY, PATTERNS, FAILURE
  • Erciyes University Affiliated: Yes

Abstract

Objectives: To assess the outcomes of overall survival and posttransplantation survival in patients with Hodgkin lymphoma (HL) undergoing autologous stem cell transplantation (ASCT) because of the development of relapse or resistance after chemotherapy (CT) or CT plus radiotherapy (combined modality treatment, CMT).